Document Detail


Secondary prevention in coronary artery disease. Achieved goals and possibilities for improvements.
MedLine Citation:
PMID:  21601296     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
AIM: To describe presence of risk indicators of recurrence 6 months after hospitalisation due to coronary artery disease at a university clinic.
METHODS: The presence of risk indicators, including tobacco use, lipid levels, blood pressure and glucometabolic status, including 24-hour blood pressure monitoring and an oral glucose-tolerance test, was analysed.
RESULTS: Of 1465 patients who were screened, 402 took part in the survey (50% previous myocardial infarction and 50% angina pectoris). Mean age was 64 years (range 40-85 years) and 23% were women. Present medications were: lipid lowering drugs (statins; 94%), beta-blockers (85%), aspirin or warfarin (100%) and ACE-inhibitors or angiotensin II blockers (66%). Values above target levels recommended in guidelines were: a) low density lipoprotein (LDL) in 40%; b) mean blood pressure (day or night) in 38% and c) smoking in 13%. Of all patients, 66% had at least one risk factor (LDL or blood pressure above target levels or current smoking). An abnormal glucose-tolerance test was found in 59% of patients without known diabetes. If no history of diabetes, 85% had either LDL or blood pressure above target levels, current smoking or an abnormal glucose-tolerance test. However, with treatment intensification to patients with elevated risk factors 56% reached target levels for blood pressure and 79% reached target levels for LDL.
CONCLUSION: Six months after hospitalisation due to coronary artery disease, despite the high use of medication aimed at prophylaxis against recurrence, the majority were either above target levels for LDL or blood pressure or continued to smoke.
Authors:
Berglind Libungan; Lillemor Stensdotter; Agneta Hjalmarson; Mona From Attebring; Jonny Lindqvist; Maria Bäck; Johan Herlitz
Related Documents :
21565506 - Raised intracranial pressure with upright posture.
21770906 - Comparison of haemodynamic responses to tracheal intubation using the airway scope(®) a...
22059786 - Diltiazem in the treatment of hypertension and ischemic heart disease.
2250126 - Whole body impedance measurements reflect total body water changes. a study in hemodial...
3294176 - Sexual dysfunction in hypertensive men. a critical review of the literature.
11765236 - Cardiopulmonary effects of three different anaesthesia protocols in cats.
Publication Detail:
Type:  Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't     Date:  2011-05-23
Journal Detail:
Title:  International journal of cardiology     Volume:  161     ISSN:  1874-1754     ISO Abbreviation:  Int. J. Cardiol.     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-10-15     Completed Date:  2013-08-05     Revised Date:  2013-10-11    
Medline Journal Info:
Nlm Unique ID:  8200291     Medline TA:  Int J Cardiol     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  18-24     Citation Subset:  IM    
Copyright Information:
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.
Affiliation:
Institute of Medicine, Department of Molecular and Clinical Medicine, Sahlgrenska University Hospital, 413 45 Göteborg, Sweden.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Aged, 80 and over
Case-Control Studies
Coronary Artery Disease / epidemiology*,  mortality,  prevention & control*
Data Collection / methods
Female
Goals*
Humans
Male
Middle Aged
Patient Discharge / trends
Risk Factors
Risk Reduction Behavior*
Secondary Prevention / methods*,  trends
Smoking / adverse effects,  epidemiology,  therapy
Comments/Corrections
Comment In:
Int J Cardiol. 2013 Sep 1;167(5):2372   [PMID:  23201080 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Twin study on transplacental-acquired antibodies and attention deficit/hyperactivity disorder - A pi...
Next Document:  Advances in farm animal transgenesis.